124 related articles for article (PubMed ID: 8786464)
1. Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation.
Gillies R; Kollias N; Hasan T; Diddens H
J Photochem Photobiol B; 1996 Mar; 33(1):87-90. PubMed ID: 8786464
[TBL] [Abstract][Full Text] [Related]
2. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic studies of photobleaching and photoproduct formation of porphyrins used in tumour therapy.
Rotomskis R; Bagdonas S; Streckyte G
J Photochem Photobiol B; 1996 Mar; 33(1):61-7. PubMed ID: 8786462
[TBL] [Abstract][Full Text] [Related]
4. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA).
Richter AM; Jain AK; Canaan AJ; Waterfield E; Sternberg ED; Levy JG
Biochem Pharmacol; 1992 Jun; 43(11):2349-58. PubMed ID: 1610400
[TBL] [Abstract][Full Text] [Related]
5. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA).
Aveline B; Hasan T; Redmond RW
Photochem Photobiol; 1994 Mar; 59(3):328-35. PubMed ID: 8016212
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate.
Jiang FN; Liu DJ; Neyndorff H; Chester M; Jiang SY; Levy JG
J Natl Cancer Inst; 1991 Sep; 83(17):1218-25. PubMed ID: 1870147
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
8. Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro.
Waterfield EM; Renke ME; Smits CB; Gervais MD; Bower RD; Stonefield MS; Levy JG
Photochem Photobiol; 1994 Oct; 60(4):383-7. PubMed ID: 7991665
[TBL] [Abstract][Full Text] [Related]
9. Application of long-circulating liposomes to cancer photodynamic therapy.
Oku N; Saito N; Namba Y; Tsukada H; Dolphin D; Okada S
Biol Pharm Bull; 1997 Jun; 20(6):670-3. PubMed ID: 9212988
[TBL] [Abstract][Full Text] [Related]
10. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
11. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
Richter AM; Waterfield E; Jain AK; Allison B; Sternberg ED; Dolphin D; Levy JG
Br J Cancer; 1991 Jan; 63(1):87-93. PubMed ID: 1989669
[TBL] [Abstract][Full Text] [Related]
12. Experimental photodynamic laser therapy for rheumatoid arthritis with a second generation photosensitizer.
Hendrich C; Hüttmann G; Vispo-Seara JL; Houserek S; Siebert WE
Knee Surg Sports Traumatol Arthrosc; 2000; 8(3):190-4. PubMed ID: 10883433
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells.
King DE; Jiang H; Simkin GO; Obochi MO; Levy JG; Hunt DW
Scand J Immunol; 1999 Feb; 49(2):184-92. PubMed ID: 10075023
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives.
Richter AM; Waterfield E; Jain AK; Sternberg ED; Dolphin D; Levy JG
Photochem Photobiol; 1990 Sep; 52(3):495-500. PubMed ID: 2284343
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis.
Peng TI; Chang CJ; Guo MJ; Wang YH; Yu JS; Wu HY; Jou MJ
Ann N Y Acad Sci; 2005 May; 1042():419-28. PubMed ID: 15965088
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic inactivation of retrovirus by benzoporphyrin derivative: a feline leukemia virus model.
North J; Freeman S; Overbaugh J; Levy J; Lansman R
Transfusion; 1992 Feb; 32(2):121-8. PubMed ID: 1371895
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
18. Predictive dosimetry for threshold phototoxicity in photodynamic therapy on normal skin: red wavelengths produce more extensive damage than blue at equal threshold doses.
Tsoukas MM; Lin GC; Lee MS; Anderson RR; Kollias N
J Invest Dermatol; 1997 Apr; 108(4):501-5. PubMed ID: 9077481
[TBL] [Abstract][Full Text] [Related]
19. Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light.
Pogue BW; Momma T; Wu HC; Hasan T
Br J Cancer; 1999 May; 80(3-4):344-51. PubMed ID: 10408836
[TBL] [Abstract][Full Text] [Related]
20. Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.
Lemoli RM; Igarashi T; Knizewski M; Acaba L; Richter A; Jain A; Mitchell D; Levy J; Gulati SC
Blood; 1993 Feb; 81(3):793-800. PubMed ID: 8427970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
